Noha Hassan Radwan

Evaluation of glypican3 in in patients with hepatocellular carcinoma / فى حالات اورام الكبد السرطانية Glypican3 تقييم Noha Hassan Radwan ; Supervised Nevine Mostafa Elhefnawi , Heba Mohammed Elzawahry , Ghada Mossallam - Cairo : Noha Hassan Radwan , 2013 - 208 P. : chats , facsimiles ; 25cm

Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Clinical Pathology

Hepatocellular carcinoma (HCC) is a major health problem. it has been increasing in Egypt with doubling in the incidence rale in the past 10 years. it represents the most common primary malignant tumor of the liver and is one of the major causes of death. early diagnosis of HCC is critical for a good prognosis.



ELISA Glypican-3 PCR